Literature DB >> 26428019

SSRI use during pregnancy.

Heather Tran1, Adelaide S Robb2.   

Abstract

The Society of Maternal and Fetal Medicine recently had a conference on the use of medications during pregnancy, delivery, and breast-feeding. One of the most important topics covered during that 2-day conference was major depression (MDD) and the use of Serotonin Selective Reuptake Inhibitors (SSRIs). This article will review the current state of knowledge about MDD during and immediately after pregnancy and treatment with SSRIs during pregnancy and breast-feeding.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26428019     DOI： 10.1053/j.semperi.2015.08.010

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN： 0146-0005            Impact factor:   3.300


  8 in total

Review 1.  Could use of Selective Serotonin Reuptake Inhibitors During Lactation Cause Persistent Effects on Maternal Bone?

Authors:  Samantha R Weaver; Laura L Hernandez
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-03-30       Impact factor: 2.673

2.  Peripartum Fluoxetine Reduces Maternal Trabecular Bone After Weaning and Elevates Mammary Gland Serotonin and PTHrP.

Authors:  Samantha R Weaver; Hannah P Fricke; Cynthia Xie; Robert J Lipinski; Chad M Vezina; Julia F Charles; Laura L Hernandez
Journal:  Endocrinology       Date:  2018-08-01       Impact factor: 4.736

3.  In utero and lactational exposure to the Selective Serotonin Reuptake Inhibitor fluoxetine compromises pup bones at weaning.

Authors:  Samantha R Weaver; Cynthia Xie; Julia F Charles; Laura L Hernandez
Journal:  Sci Rep       Date:  2019-01-18       Impact factor: 4.379

4.  Editorial: Reproductive Events in Women With Mood Disorders: Advances in Knowledge and Management.

Authors:  Gianluca Rosso; Prabha S Chandra
Journal:  Front Psychiatry       Date:  2021-11-30       Impact factor: 4.157

5.  Pregnancy Complications and Neonatal Mortality in a Serotonin Transporter Null Mouse Model: Insight Into the Use of Selective Serotonin Reuptake Inhibitor During Pregnancy.

Authors:  Rafael R Domingues; Milo C Wiltbank; Laura L Hernandez
Journal:  Front Med (Lausanne)       Date:  2022-03-10

6.  Fluoxetine-induced perinatal morbidity in a sheep model.

Authors:  Rafael R Domingues; Adam D Beard; Meghan K Connelly; Milo C Wiltbank; Laura L Hernandez
Journal:  Front Med (Lausanne)       Date:  2022-08-04

7.  Perinatal MAO Inhibition Produces Long-Lasting Impairment of Serotonin Function in Offspring.

Authors:  Mark W Burke; Myriam Fillion; Jose Mejia; Frank R Ervin; Roberta M Palmour
Journal:  Brain Sci       Date:  2018-06-11

8.  Effect of Low and High Doses of Two Selective Serotonin Reuptake Inhibitors on Pregnancy Outcomes and Neonatal Mortality.

Authors:  Rafael R Domingues; Hannah P Fricke; Celeste M Sheftel; Autumn M Bell; Luma C Sartori; Robbie S J Manuel; Chandler J Krajco; Milo C Wiltbank; Laura L Hernandez
Journal:  Toxics       Date:  2022-01-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.